GlassScriptPhysician profile
Hsiaoping Chou
NPI 1265706410
$2,614.60
in general payments reported to CMS, 2019-2025
14 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 85% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $181 · 2023: $740 · 2024: $530 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,232.59 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,430.80 | 2021-2025 | |
| Janssen Biotech, INC. | $378.99 | 2022-2025 | Tremfya, Stelara, Simponi |
| Ardelyx, INC. | $132.79 | 2023-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $123.94 | 2024-2025 | Voquezna |
| Intra-Sana Laboratories | $91.76 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Abbvie INC. | $87.33 | 2024-2025 | |
| Celltrion USA INC. | $75.48 | 2025 | Vegzelma |
| Takeda Pharmaceuticals U.S.A., INC. | $68.30 | 2023-2024 | Entyvio |
| Janssen Pharmaceuticals, INC | $57.33 | 2023 | Xarelto |
| Nestle Healthcare Nutrition INC. | $51.18 | 2023 | |
| Evoke Pharma, INC. | $48.98 | 2023 | Gimoti |
| Madrigal Pharmaceuticals | $26.89 | 2025 | Rezdiffra |
| Redhill Biopharma INC. | $24.23 | 2023 | Talicia |
| Chiesi USA, INC. | $16.60 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsiaoping Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.